Tonight and tomorrow on #NephJC we discuss the NEFIGARD trial of #Nefecon (a targeted release #budesonide) in #IgANephropathy - supposedly with no systemic steroid exposure - but read the summary and decide for yourself http://www.nephjc.com/news/nefigard-trial
#nephrology #glomerulonephritis
#VisualAbstract from @Priti899
#NephJC #nefecon #budesonide #iganephropathy #Nephrology #glomerulonephritis #visualabstract